Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel P Murray

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Archivos Espanoles De Urologia|June 15, 2017
[Comparison of two on-line risk calculators versus the detection of circulating prostate cells for the detection of high risk prostate cancer at first biopsy.]Nigel P Murray, Cynthia Fuentealba, Eduardo Reyes, et al.
Turkish Journal of Urology|February 14, 2020
Platelet-to-lymphocyte ratio and systemic immune-inflammation index versus circulating prostate cells to predict significant prostate cancer at first biopsyNigel P Murray, Cynthia Fuentealba, Aníbal Salazar, et al.
Ecancermedicalscience|March 10, 2017
CD19 <sup>(+)</sup> CD56 <sup>(-)</sup> myeloma arising in a patient who failed two courses of immunosupressive therapy for aplastic anaemiaNigel P Murray, M Amparo Ruiz, G Maximiliano Miranda
Asian Pacific Journal of Cancer Prevention : APJCP|March 17, 2015
Diagnostic yield of primary circulating tumor cells in women suspected of breast cancer: the BEST (Breast Early Screening Test) studyNigel P Murray, Roxana Miranda, Amparo Ruiz, et al.
Hematology, Transfusion and Cell Therapy|February 24, 2021
Management of mild congenital deficiency of Factor XI with a Factor XI inhibitor in pregnancy: A clinical caseNigel P Murray, Javier Ilabaca, Eghon Guzman, et al.
Case Reports in Obstetrics and Gynecology|December 20, 2014
Management of Pregnancy in a Chilean Patient with Congenital Deficiency of Factor VII and Glanzmann's Thrombasthenia VariantNigel P Murray, Claudio Garcia, Javier Ilabaca, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|August 12, 2016
Efficacy of Using Sequential Primary Circulating Prostate Cell Detection for Initial Prostate Biopsy in Men Suspected of Prostate CancerNigel P Murray, Eduardo Reyes, Cynthia Fuentealba, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|November 10, 2020
The association of the neutrophil-lymphocyte ratio with the presence of minimal residual disease and outcome in patients with Stage II colon cancer treated with surgery aloneNigel P Murray, Ricardo Villalon, Shenda Orrego, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|June 26, 2018
10 Year Biochemical Failure Free Survival of Men with CD82 Positive Primary Circulating Prostate Cells Treated by Radical ProstatectomyNigel P Murray, Socrates Aedo, Cynthia Fuentealba, et al.
Archivos Espanoles De Urologia|May 8, 2013
Cost-Benefit of incorporating the detection of circulating prostate cells in a screening programme for prostate cancerNigel P Murray, Eduardo Reyes, Nelson Orellana, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Archivos Espanoles De Urologia|June 15, 2017
[Comparison of two on-line risk calculators versus the detection of circulating prostate cells for the detection of high risk prostate cancer at first biopsy.]Nigel P Murray, Cynthia Fuentealba, Eduardo Reyes, et al.
Turkish Journal of Urology|February 14, 2020
Platelet-to-lymphocyte ratio and systemic immune-inflammation index versus circulating prostate cells to predict significant prostate cancer at first biopsyNigel P Murray, Cynthia Fuentealba, Aníbal Salazar, et al.
Ecancermedicalscience|March 10, 2017
CD19 <sup>(+)</sup> CD56 <sup>(-)</sup> myeloma arising in a patient who failed two courses of immunosupressive therapy for aplastic anaemiaNigel P Murray, M Amparo Ruiz, G Maximiliano Miranda
Asian Pacific Journal of Cancer Prevention : APJCP|March 17, 2015
Diagnostic yield of primary circulating tumor cells in women suspected of breast cancer: the BEST (Breast Early Screening Test) studyNigel P Murray, Roxana Miranda, Amparo Ruiz, et al.
Hematology, Transfusion and Cell Therapy|February 24, 2021
Management of mild congenital deficiency of Factor XI with a Factor XI inhibitor in pregnancy: A clinical caseNigel P Murray, Javier Ilabaca, Eghon Guzman, et al.
Case Reports in Obstetrics and Gynecology|December 20, 2014
Management of Pregnancy in a Chilean Patient with Congenital Deficiency of Factor VII and Glanzmann's Thrombasthenia VariantNigel P Murray, Claudio Garcia, Javier Ilabaca, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|August 12, 2016
Efficacy of Using Sequential Primary Circulating Prostate Cell Detection for Initial Prostate Biopsy in Men Suspected of Prostate CancerNigel P Murray, Eduardo Reyes, Cynthia Fuentealba, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|November 10, 2020
The association of the neutrophil-lymphocyte ratio with the presence of minimal residual disease and outcome in patients with Stage II colon cancer treated with surgery aloneNigel P Murray, Ricardo Villalon, Shenda Orrego, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|June 26, 2018
10 Year Biochemical Failure Free Survival of Men with CD82 Positive Primary Circulating Prostate Cells Treated by Radical ProstatectomyNigel P Murray, Socrates Aedo, Cynthia Fuentealba, et al.
Archivos Espanoles De Urologia|May 8, 2013
Cost-Benefit of incorporating the detection of circulating prostate cells in a screening programme for prostate cancerNigel P Murray, Eduardo Reyes, Nelson Orellana, et al.
Pageof 8